Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)
Close on Nov 18, 2026Market cap $691.46MP/E –Yield –
Fulgent Genetics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Fulgent Genetics's market cap was $707.14M on Nov 11, 2026, against $912.66M a year earlier. Over the last 5 years it ranged from $472.12M to $3.00B, with a median of $715.27M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $707.14M | -12.8% |
| 2025 | Dec 31, 2025 | $810.53M | +43.7% |
| 2024 | Dec 31, 2024 | $564.02M | -35.0% |
| 2023 | Dec 29, 2023 | $868.31M | -1.8% |
| 2022 | Dec 30, 2022 | $883.90M | -70.5% |
| 2021 | Dec 31, 2021 | $3.00B | +147.1% |
| 2020 | Dec 31, 2020 | $1.21B | +404.1% |
| 2019 | Dec 31, 2019 | $240.88M | +320.8% |
| 2018 | Dec 31, 2018 | $57.24M | -26.5% |
| 2017 | Dec 29, 2017 | $77.84M | -47.6% |
| 2016 | Dec 30, 2016 | $148.63M | – |
See a number that looks wrong?